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There are several reasons why effective preservation techniques playa crucial role 
in orthotopic transplantation of the human liver. The liver is especially sensitive to 
the effects of anoxia although the rate of injury can be markedly reduced by 
prompt cooling. 1- 3 The technical difficulties of recipient total hepatectomy may 
be time consuming, requiring many hours. In addition, it may be necessary to invest 
postmortem time for the performance of histocompatibility tests on prospective re-
cipients and the potential donor. Finally, the penalty for failure to provide a well-
functioning organ is death of the recipient, as survival in the functionally anhepatic 
state is possible for only a brief interval. 
For a number of years, research in whole-organ liver preservation provided 
little reason for optimism. In dogs it was soon learned that prompt core cooling 
with chilled perfusates provided a safe ischemic time of about 2 hr. 1,2 When perfu-
sion was added to hypothermia, Mikaeloff and Kestens et al. 4 and Marchioro et al. 5 
were able to extend organ viability after donor death; however, both of these sys-
tems involved in-situ techniques. Attempts to excise the liver and preserve it out-
side the donor body were uniformly unsuccessful. 
During the last year and a half, it has been established that livers can be main-
tained in good condition for many hours after their extirpation. It is the purpose of 
this report to describe the techniques which have made possible these experimental 
results and the subsequen t successful clinical application of the same methods. 
Supported by U.S. Public Health Service Grants AM-D6344, HE·07735, AM-D7772, 
AI-04152, FR-00051, FR-00069, F05-TW-1154, AM-12148, and AI-AM-08898. 
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EXPERIMENTAL STUDIES 
Hypothermia, hyperbaric oxygenation, and low-flow perfusion through the 
portal vein and hepatic artery were used together to preserve livers of dogs which 
were first cooled to 30-32°C and sacrificed by performance of total hepatectomy. 
In all experiments, the organs were further cooled by infusion with a chilled solu-
tion, then preserved, and finally evaluated after placement as orthotopic homo-
grafts in nonrelated mongrel recipients (Fig. 1). The test system is a technically dif-
ficult one, but it has the overriding advantage that the life of the recipient animal 
is dependent upon the new organ at all times subsequent to operation. Thus, de-
cisive information can be obtained about both the early and chronic function of 
the preserved organs and the influence of variations in methodology on the results 
...-----Upper Vena C~va 
anaetomOSl$ 
~~=::::::::--
Fig. 1. Technique of orthotopic liver transplantation in dogs. Arterial supply is derived from 
proximal part of common hepatic artery by end-to-end anastomosis to proximal part of recip-
ient hepatic artery. Distal portion of recipient artery and its inferiorly directed branches are 
left undisturbed; failure to do so may result in duodenal necrosis. (By permission of Surgery, 
Gynecology & Obstetrics [126:263, 1968).) 
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during both periods of convalescence. The effects of several modifications in tech-
nique were analyzed as previously reported elsewhere,6 and these findings will be 
summarized below. 
OPTIMAL TECHNIQUE 
The best results were obtained when hypothermia (4°C) and hyperbaric oxy-
genation (40 psig) were combined with perfusion of the portal vein and hepatic ar-
tery with diluted blood at a total flow rate of 6 milliliters per gram liver tissue per 
hour; the portal vein to hepatic arterial flow ratio was 4: 1. The way in which can-
nulas were used to connect to the pump system is shown in Fig. 2. A simple baffle 
runoff system placed within the hyperbaric chamber provided adequate oxygena-
tion. At the end of the preservation period, the chamber was decompressed slowly 
over a period of 180 to 240 min. 
Fig. 2. Preservation unit. Perfusion pumps are located outside hyperbaric chamber. Organ re-
ceptacle, oxygenator, and venous reservoir are inside. Various chamber inlets permit sampling 
of perfusate, gas sterilization, and oxygen delivery and removal. Temperature is electronically 
controlled. (By permission of Surgery, Gynecology & Obstetrics [126:263, 1968].) 
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The composition of the perfusate was one part homologous blood per one 
part balanced electrolyte solution * containing 5.0 g% low-molecular-weight de x-
tran,t 150 mg% glucose, 2 mEq/L magnesium sulfate, 50 mg/L procaine, 100 mg/L 
heparin, and sufficient sodium bicarbonate to adjust the final pH to 7.4-7.5. A glass 
wool filter was inserted at the runoff of the baffle and standard intravenous blood 
filters were placed in both the inflow lines. 
It was found that livers preserved in this way for 8 to 9% hr invariably 
functioned well immediately after transplantation to mongrel dogs. In five such ex-
periments the recipients survived operation for more than 5 postoperative days. 
Furthermore, chronic survival in these animals, which were treated with azathio-
prine, prednisone, and heterologous antilymphocyte globulin, was not significantly 
different (Table 1, Group ID) than in a series of control experiments in which 
transplantation was carried out as rapidly as possible without the intervening period 
of preservation (Table 1, Controls). Tlle biochemical evidence of ischemic injury 
after transplantation was mild-to-moderate and highly reversible-at least in terms 
of changes in SGOT and SGPT and other measures of liver function. 
With use of the same technique,S more livers were preserved for 24 hI. Two 
recipients of these organs died during or just after operation from an uncontrol-
lable hemorrhagic diathesis. The other 3 (Table 1, Group IE) lived for 8, 46, and 
128 days (Fig. 3). 
• 
REDUCED PERFUSION RATES 
The same experiment was performed in 10 animals but with half the rates of 
total perfusion. Survival at operation was obtained in 90 percent of the animals 
(Table 1, Groups 1 Band 1 C) but only 4 of the 10 lived beyond 5 days. Even in the 
occasional long-term survivor there was evidence of moderate-to-severe ischemic in-
jury with high rises in the serum transaminases and the early appearance of jaun-
dice (Fig. 4). In less fortunate animals a characteristic syndrome was observed. 
First, the operative bleeding was often extremely difficult to control-a fact fully 
explained by multiple and rapidly developing abnormalities of coagulation detected 
in the same animals by Pechet et al. 7 Second, many of the recipients in which 
hemostasis was finally obtained had subsequent evidence of acute hepatic insuffi-
ciency.- Postoperative hypoproteinemia was common. Massive fluid therapy was 
usually necessary, apparently because of "third-space" sequestration. Serial electro-
phoretic studies in such dogs showed the disappearance of multiple protein con-
stituents which are ordinarily present in small quantities. This resulted in a 
"stripped tree" appearance (Fig. 5), indicating the presence of reduced protein 
synthesis and/or an increased overturn of the various protein fractions. With the 
passage of time, the absent protein lines tended to return (Fig. 5), but usually in-
completely by the time of death. Gastrointestinal hemorrhage was frequently a de-
*Travenol Laboratories, Inc., Morton Grove, Ill. 
tPharmacia Laboratories, Inc., Piscataway, New Market, N.J. 
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Fig. 3. Course of dog which received orthotopic liver homograft preserved for 24% hr. Per-
fusion rate was twice that used for experiment shown in Fig. 4. There is relatively minor bio-
chemical evidence of early ischemic injury. Dog died after 128 days; immunosuppression was 
stopped after 120 days. 
SGPT 
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Fig. 4. Course of dog which received orthotopic liver homograft after preservation for 14'h hI. 
Total liver perfusion was only 3 ml/g/hr, a rate thought to be inadequate. Note early evidence 
of reversible ischemic injury. Later rise in SGPT was probably caused by low-grade rejection. 
This dog, as well as all others in the study, was treated with azathioprine, short postoperative 
course of prednisone, and antilymphocyte globulin; immunosuppression was stopped after 4 
months. Dog died after 274 postoperative days. 
layed cause of death. The overall picture was one which could be explained by a 
general impairment of liver function. These latter findings emphasize the impor-
tance of not judging the adequacy of preservation techniques simply by the ability 
to achieve operative survival. 
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Fig. 5. Changes seen by immunoelectrophoresis in serum of dog which received damaged liver 
homograft. Note early postoperative disappearance of several precipitation bends including 
ceruloplasmin (Cp), ~MD a2L> 131A' 'YM' and 'YA" These tended to return, but never completely, 
to control status. (By permission of Surgery [63:247, 1968].) 
RAPID CHAMBER DECOMPRESSION 
In all the foregoing experiments in which either the higher or the reduced 
flow rates were used, the hyperbaric chamber was gradually decompressed during 3 
to 4 hours at the end of the preservation period. The organs did not tend to gain 
weight even after as long as a day (Table 1, Groups lB-E). 
In another series of experiments (Table 1, Group 1A), similar low flow per-
fusion was carried out but the chamber was decompressed in 30 min. Weight gain of 
the homografts was a prominent finding, averaging 16.6 percent. An additional 
complication was the development of gas bubbles within the organ. These issued 
forth in the residual fluid in the major vessels and could be identified within the 
parenchyma by x-ray examination. After the livers were revascularized, some of 
the dogs did not awaken and it was suspected that they had suffered air emboliza-
tion. Although 6 of the 7 recipients survived operation, and 4 lived longer than 5 
days, all were dead by the ninth postoperative day. 
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OMISSION OF HYPERBARIC OXYGENATION 
Three homografts were preserved for approximately a day by using the high-
er flow perfusion described earlier and with 100 percent oxygen at ambient pres-
sure. The oxygen tension of the perfusate was maintained at about 250 mm Hg. 
The homograft weight gain was greater (27.1 percent average) than in any other ex-
perimental group in this study (Table 1, Group 2). Two of the recipients of these 
organs bled to death after revascularization, and the third died after 28 hours. 
OMISSION OF PERFUSION 
Three homografts were placed in the cold hyperbaric chamber at a pressure 
of 40 psig, and not perfused. Two of the recipients of these organs failed to sur-
vive operation (Table 1, Group 3) and the third died after 3% days. The last ani-
mal never awakened from anesthesia. 
EVALUATION OF ACELLULAR PERFUSATES 
Unsatisfactory homografts were obtained when the balanced and oncotically 
controlled salt solutions used to dilute the homologous blood were used for 24-hr 
perfusions (Table 1, Group 4). Two of the organs did not immediately support life 
and the recipient of the third had poor liver function during the survival period of 9 
days. 
In five more experiments, hemoglobin was prepared with Folkman's modifi-
cations of Pennell's technique9 and added to the above solution so that the final 
hemoglobin concentration was 5 to 7 g%. The electrolyte composition and pH 
were adjusted to that of normal whole blood. Five livers perfused at 6 milliliters per 
gram liver tissue per hour for 8 to 10% hr were apparently badly damaged. Only 
one of the recipients of these organs survived operation (Table 1, Group 5), and 
that animal died after 5 days. 
In a final group of experiments, homologous plasma was added to an equal 
volume of balanced and oncotically controlled solution; the technique was similar 
to that described by Slapak et aL 10 Five organs were perfused at 6 milliliters per 
gram liver tissue per hour for 9% to 10* hr. Three of th~ 5 recipients survived oper-
ation and 2 of these animals lived for 19 days. The mediocre results in these trials 
may be. explained by our failure to remove the lipoprotein flocculate which Belzer 
has demonstrated to be an extremely adverse factor in plasma perfusion systems 
used for kidney preservation. ll 
CLINICAL APPLICATION 
The most effective of the above techniques (Groups 10 and IE) has been 
used fo:r preservation of 7 cadaveric human livers. Pains were taken to reduce 
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Fig. 6. Core cooling of cadaveric liver used for infant donors. Immediately after entering ab-
domen, cannula is placed into readily accessible superior measenteric vein. s~ssel is far enough 
away from portal triad so portal vein, ultimately used for anastomosis, is not in danger of in-
jury. Egress of perfusion fluid is provided by venotomy in suprahepatic inferior vena cava. Bile 
is washed from gallbladder tluough cholecystotomy. Adult donors livers were cooled by total 
body extracorporeal perfusion and flushing carried out after completion of hepatectomy. (By 
permission of Annals of Surgery [168:Sept., 1968].) 
postmortem damage before delivery of the organs to the chamber. The most im-
portant step was rapid cooling. 
This was accomplished in the infant donors by immediate insertion of an in-
fusion catheter into the easily accessible superior mesenteric vein, which was iso-
lated and cannulated within a few minutes after death (Fig. 6). By keeping the dis-
section away from the portal tract, the possibility of injury to the major hilar 
structures was circumvented. During portal perfusion egress for the fluid was pro-
vided by venotomies in the vena cava (Fig. 6). A possibly important precaution was 
lavage of the gallbladder for the purpose of preventing postmortem autolysis of the 
extrahepatic biliary system. 
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Fig. 7. Technique of extracorporeal cadaver perfusion. Catheters are inserted via fermoral ves-
sels into aorta and vena cava as soon as possible after death. Extracorporeal circuit is primed 
with heparinized glucose or electrolyte solution with procaine added. Cadaver is anticoagulated 
with fIrst surge of pump. Temperature control is provided by heat exchanger. (By permission 
of the W. B. Saunders Co., Philadelphia, 1964.) 
Adult donors were cooled in a different way (Fig. 7). As soon as possible 
after the pronouncement of death, catheters were inserted via the femoral vessels 
into the abdominal aorta and vena cava. The cadavers then had circulation restored 
with an extracorporeal heart-lung machine which contained a heat exchanger. 5 The 
cadaver could be core-cooled to approximately 10°C within a half-hour at the same 
time as donor hepatectomy was being performed. The perfusion used was initially 
30 to 50 milliliters per kilogram body weight per minute but after 15 -30 min 
this was reduced to as low as 10 ml/kg/min. 
After being removed, the cooled livers were first cleared of blood' by infusing 
a balanced and oncotically controlled electrolyte solution through the portal and 
arterial routes. The organs were then placed in the hyperbaric chamber and per-
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fused at a flow rate of 6 ml/g/hr exactly as in the most successful experimental 
group described in the preceding section. Special precautions were taken to insure 
that the blood donor for the perfusate was compatible by direct crossmatching 
with the liver donor and the prospective recipient. The time between donor death 
and revascularization of the homografts in the 7 cases was 242 to 427 min. 
All 7 of these livers provided adequate immediate function, although there 
were always acute postoperative declines in plasma protein concentrations (Figs. 
8 and 9). In each case there were rises in serum transaminases the morning after 
operation but these rises did not reach high levels and were quickly reversed. The 
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Fig. 8. Course of 24-month-old child after orthotopic liver homotransplantation for extra-
hepatic biliary atresia. Jaundice has not recurred, although subclinical rejection was diagnosed 
from third to seventh postoperative weeks because of rises in alkaline phosphatase, SGOT, and 
SGPT; these changes have receded. By 4 weeks, all antibiotic therapy was stopped. Child has 
since been afebrile. Temperatures are maximums for each day. (By permission of Annals of 
Surgery [168:Sept., 1968].) 
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Fig. 9. Early postoperative course of 16-year-old girl who received homograft. Note absence 
of striking rises in early postoperative transaminases. Beginning 5 days after transplantation 
abnormalities of liver function became evident, but these were thought to be caused by re-
jection, as indicated in graph. Rejection was easily controllable and she is in good condition 
6 Y2 weeks post-transplantation. 
ensuing events in these cases were determined by the severity of subsequent rejec-
tion and by other factors that have been fully described elsewhere.12,13 
For example, the course of a child with extrahepatic biliary atresia is shown 
graphically in Fig. 8. His serum bilirubin level before transplantation was more 
than 31 mg%. The hyperbilirubinemia rapidly resolved within a few days after op-
eration. An overt rejection crisis has not been seen although there were transient 
rises in SGOT and SGPT during the second postoperative month. 
The minor degree of liver injury caused during the terminal course of the 
donor and during the times of organ removal and preservation can be even better 
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appreciated by observing the convalescence of a hepatoma patient who was not 
jaundiced (Fig. 9). This recipient was 16 years old and weighed 39 kg. Her donor 
was an 82-kg man, 27 years old, who died of a gunshot wound of the head. Both 
patients were Blood Type O. The time from donor death to revascularization in the 
recipient was 7 hr and 7 min. The organ functioned immediately and essentially 
normally until the onset of an indolent and controllable rejection on the fifth 
postoperative day. 
The good early function in these 2 cases as well as in the 5 others is evidence 
of the efficiency and practicality of the preservation system. In one instance, the 
prospective recipient was leaving Chicago for Denver when the donor died. The or-
gan was conserved until he arrived and was prepared for hepatectomy; the time 
from donor death to homograft revascularization was 6 hI. 
Four of these 7 patients are still alive 2h weeks, 1 h months, 3 months, and 
9h months post-transplantation. The other 3, as well as a fourth patient who re-
ceived a non preserved liver, died after 2, 3h, 4h, and 6 months. Failure to provide 
an immediately functioning and life-sustaining homograft was not a factor in the un-
favorable outcome in any of these cases. 
SUMMARY 
An effective method for preserving whole-organ liver homografts has been 
tested in the laboratory and applied clinically. The technique involves a combina-
tion of hyperbaric oxygenation, hypothermia, and perfusion with diluted blood. 
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